In our study, high ATM expression was correlated with clinicopathological features and poor prognosis of ovarian cancer patients, whereas the inhibition of ATM expression is expected to become a potential therapy for patients with ovarian cancer. The gene discussed is ATM; the disease is ovarian carcinoma.